I'm pretty sure buproprion was made by synthesizing a bunch of analogues (2, 3, 4- chloro, 2, 3, 4 - methoxy, N-isopropyl, N-t-butyl, etc etc) and picking the one with the most favorable binding affinities & kinetics.
You're being too reductionist here. The reuptake inhibition properties comes from the fact it's a cathinone. The selectivity for is increased because of the t-butyl substituent (as it gets metabolically hydroxylated & turns to a cyclic NDRI called
radafaxine aka 6-hydroxy-buproprion.
The t-butyl group on the nitrogen probably contributes more to the extended half life - but it also adjusts selectivity for the monoamine transporters, away from serotonin & dopamine. The chloro substitution helps tune selectivity even more. But both of these work in concert with the cathinone structure; you can't really generalise and say "the t-butyl group is responsible for blocking uptake" - because plain cathinone blocks transporters quite well!